Uploaded on Aug 9, 2021
According to our latest study on “Irritable Bowel Syndrome (IBS) Treatment Market Forecast to 2028 – COVID-19 Impact and Global Analysis – by Type, Product, and Distribution Channel,” the market was valued at US$ 2,153.89 million in 2020 and is projected to reach US$ 4,600.30 million by 2028; it is expected to grow at a CAGR of 10.1% from 2021 to 2028. The report highlights the key factors driving the market growth and prominent players with their developments in the market. Download Exclusive Sample PDF of this Report @ https://www.theinsightpartners.com/sample/TIPRE00006814/?utm_source=FreePlatform&utm_medium=10225
Irritable Bowel Syndrome (IBS) Treatment Market - Comprehensive Evaluation of the Market via in-Depth Qualitative Insights
Irritable Bowel Syndrome
(IBS) Treatment Market US$ 4,600.30 million
Forecast to 2028
8
02
1–
2
20
2
COVID-19 Impact and grin
Global Analysis du
.1%
of
10
R
By Type [IBS with AGC
Diarrhea (IBS-D), IBS t a
with Constipation (IBS- w
a
C), and Mixed IBS (IBS- oGr
M)]
US$ 2,153.89 million
Product (Rifaximin,
Eluxadoline,
Lubiprostone,
Linaclotide, and
Others)
2021 2028
Table of Content
Irritable Bowel Syndrome Irritable Bowel Syndrome
(IBS) Treatment Market (IBS) Treatment Market –
Landscape Geographic Analysis
Irritable Bowel Syndrome Irritable Bowel Syndrome
(IBS) Treatment Market – (IBS) Treatment Market -
Key Market Dynamics Covid-19 Impact Analysis
Irritable Bowel Syndrome Industry Landscape
(IBS) Treatment – Global
Market Analysis
Global Irritable Bowel Company Profiles
Syndrome (IBS) Treatment
Market Analysis – By Type
The Global Irritable Bowel Syndrome (IBS) Treatment
Market has been Segmented as Mentioned Below:
By Type By Product
• IBS with Diarrhea • Rifaximin
(IBS-D) • Eluxadoline
• IBS with • Linaclotide
Constipation (IBS-C) • Lubiprostone
• Mixed IBS (IBS-M) • Others
By Geography By Distribution Channel
• North America • Hospitals
• Europe Pharmacies
• Asia Pacific • Drug Stores and
(APAC) Retail Pharmacies
• Middle East & • Online
Africa Pharmacies
Report Progress
Publication Month: Report Code:
May 2021 TIPRE000068
14
Status: No. of Pages:
Published 180
Download Research Sample Pages @
https://www.theinsightpartners.com/sample/TIPRE00006814/
The List of Companies - Irritable Bowel Syndrome (IBS) Treatment
Market
Company Profiles
• Ironwood
Pharmaceuticals, Inc.
• AbbVie.
• Sebela Pharmaceuticals,
Inc.
• Takeda Pharmaceutical
Company Limited
• Alfasigma S.p.A.
• Astellas Pharma Inc.
• AstraZeneca
• Synthetic Biologics, Inc.
• Bausch + Lomb
Incorporated
• Lannett Company Inc
Frequently Asked Questions
What are reasons behind Irritable
Bowel Syndrome (IBS) Treatment
market growth?
What are market opportunities for
Irritable Bowel Syndrome (IBS)
Treatment market?
Which type of valve is expected to
dominate the market in the forecast
period?
Which sector is expected to dominate
the market in the forecast period ?
What trends are expected to drive the
demand for various Irritable Bowel
Syndrome (IBS) Treatments ?
Get all Answers @ https://www.theinsightpartners.com/reports/irritable-bowel-syndrome-treatment-market
Reasons To Buy This
Report
• Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the global
Irritable Bowel Syndrome (IBS) Treatment market.
• Highlights key business priorities in order to assist companies to realign their business strategies.
• The key findings and recommendations highlight crucial progressive industry trends in the global automated waste collection system
market, thereby allowing players across the value chain to develop effective long-term strategies.
• Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
• Scrutinize in-depth global market trends and outlook coupled with the factors driving the market, as well as those hindering it.
• Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to client
products, segmentation, pricing, and distribution.
Buy This Report @
https://www.theinsightpartners.com/buy/TIPRE00006814/
Contact Us for More Details
UNITED STATES : FOR SALES :
• Contact Person : Sameer Joshi • Contact Person : Karan Joshi
• Phone : +1-646-491-9876 • Phone : +91-20-67271632
• E-mail : • E-Mail :
[email protected] [email protected]
Comments